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 CURRENTOPINION Prebiotics, probiotics, synbiotics, and the immune
system: experimental data and clinical evidence
Remo Frei a,b, Mu¨beccel Akdisa, and Liam O’Mahonya
Purpose of review
The intestinal immune system is constantly exposed to foreign antigens, which for the most part should be
tolerated. Certain probiotics, prebiotics, and synbiotics are able to influence immune responses. In this
review, we highlight the recent publications (within the last 2 years) that have substantially progressed this
field.
Recent findings
The immunological mechanisms underpinning probiotics, prebiotics, and synbiotics effects continue to be
better defined with novel mechanisms being described for dendritic cells, epithelial cells, T regulatory cells,
effector lymphocytes, natural killer T cells, and B cells. Many of the mechanisms being described are
bacterial strain or metabolite specific, and should not be extrapolated to other probiotics or prebiotics. In
addition, the timing of intervention seems to be important, with potentially the greatest effects being
observed early in life.
Summary
In this review, we discuss the recent findings relating to probiotics, prebiotics, and synbiotics, specifically
their effects on immunological functions.
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INTRODUCTION
The mammalian gastrointestinal tract is a highly
evolved system specialized to perform the essential
functions of nutrient digestion, absorption, and
waste disposal. The intestinal immune system has
the unenviable task of maintaining intestinal integ-
rity in the presence of vast quantities of external or
foreign antigens. Sophisticated cellular and mole-
cular networks need to be constantly coordinated in
order to tolerate nonpathogenic antigens, while
also protective immune responses to potential
pathogens must be maintained and can be induced
effectively on demand. Inappropriate immune
response to bacterial or dietary antigens is a signifi-
cant component in several intestinal diseases,
including inflammatory bowel disease, irritable
bowel syndrome, and food allergies [1,2].
The balance between immune tolerance and
inflammation is regulated in part by the crosstalk
between innate and adaptive immune cells and the
intestinal microbiota. Disrupted communication
between the microbiome and the host because of
altered composition and metabolism is thought
to negatively influence the intestinal immune
homeostatic networks. The deliberate modification
of microbial species and their metabolism has led to
the probiotic and prebiotic concepts [3].
Probiotics can be defined as live micro-
organisms which, when administered in adequate
amounts, confer a health benefit on the host. Nota-
bly, the definition of a probiotic does not differen-
tiate between the wide range of potential health
benefits and it is clear that not all probiotics will
influence the immune system in the same way. In
this review, we have focused on the probiotic studies
with immunological endpoints, but these findings
cannot be extrapolated to other probiotic strains. In
addition, we have included microbial species not
currently used in the industry as probiotics, even
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though these microbes fulfill the definition pro-
vided above.
Prebiotics can be defined as selectively fer-
mented ingredients that allow specific changes,
both in the composition and in the activity of the
gastrointestinal microflora, which confer benefits
upon host well being and health. Prebiotics typically
are fibers that cannot be digested by the host, but are
metabolized by the colonic microbiome resulting in
expansion of certain bacterial species and the release
of metabolites, such as short-chain fatty acids
(SCFAs). As with the probiotic definition, not all
prebiotics will have the same effect on immuno-
logical functions.
The combination of probiotics and prebiotics is
termed ‘synbiotics’.
INNATE IMMUNE SYSTEM
The innate immune system is comprised of many
different cell types, and these cells are often the first
cells to come in contact with intestinal microbes
and their metabolic products. The most commonly
described cell types in the probiotics and prebiotics
literature are dendritic cells and epithelial cells.
Dendritic cells
Intestinal dendritic cells are located within specific
intestinal lymphoid tissues, collectively termed gut-
associated lymphoid tissues (GALT), or diffusely
distributed throughout the intestinal lamina prop-
ria [4]. Dendritic cells are the primary cell type
involved as ‘sensors’ of microbial ligands through
activation of innate immune receptors (e.g. Toll-like
receptors and c-type lectin receptors). The signaling
pathways triggered by bacterial-derived molecules
allow for changes in dendritic cell phenotypes and
cytokine secretion, which underlie the integration
of microbial and host metabolism with immune
functions. Metabolism of vitamin A to retinoic acid
is a key immunomodulatory activity associated with
intestinal dendritic cells [5
&
]. Certain, but not all,
probiotic microbes can induce retinoic acid meta-
bolism by human dendritic cells in vitro and by
murine CD103þ dendritic cells within the small
intestine lamina propria [6
&
,7]. In addition to
vitamin A metabolism, induction of another
dendritic cell metabolic enzyme, heme oxygenase-
1 (HO-1), was shown to be required for the induc-
tion of mucosal T regulatory (TREG) cells within the
mesenteric lymph nodes by Lactobacillus rhamnosus
[8].
Bacterial cell wall components and metabolites
have been associated with the immunoregulatory
effects on dendritic cells. For example, major histo-
compatibility complex (MHC)-II-dependent presen-
tation of segmented filamentous bacteria antigens
by intestinal CD11cþ dendritic cells is crucial for the
local induction of TH17 lymphocytes [9
&&
]. In
addition, capsular polysaccharide A (PSA) from Bac-
teroides fragilis has been shown to interact directly
with mouse plasmacytoid dendritic cells via TLR-2.
PSA-exposed plasmacytoid dendritic cells express
molecules involved in protection against colitis
and stimulated CD4þ cells to secrete IL-10 [10&].
An exopolysaccharide from Bacillus subtilis prevents
gut inflammation stimulated by Citrobacter roden-
tium, which is dependent on TLR-4 and MyD88
signaling [11
&
].
The production of SCFAs occurs in the colon
following fermentation of dietary fibers, such as
prebiotics [12]. Abnormalities in the production of
these metabolites (because of dietary factors and
dysbiosis) might play a role in the pathogenesis of
type 2 diabetes, obesity, inflammatory bowel dis-
ease, colorectal cancer, and allergies [13]. Among
the SCFAs, butyrate seems to be more potent than
acetate or propionate in inducing immunomodula-
tory effects. Butyrate influences the activity of
histone deacetylases (HDAC), which is responsible
for decreasing dendritic cell IL-12 and IL-6 cytokine
secretion and allows dendritic cells to promote TREG
cells. Propionate can also contribute to the induc-
tion of Foxp3 expression by dendritic cells, whereas
acetate does not have this activity possibly because
of the lack of HDAC activity [14
&
]. Butyrate also
inhibits intestinal macrophage HDAC [15
&&
].
Another recent study has confirmed and extended
the observation that butyrate promotes dendritic
cell regulatory activity, resulting in the induction
of TREG cells and IL-10-secreting T cells. These effects
were mediated by the G-protein-coupled receptor
Gpr109a on colonic dendritic cells and macro-
phages [16
&
]. In contrast, butyrate has also been
shown to promote IL-23 secretion by murine den-
dritic cells, which may promote TH17 responses
under certain circumstances [17].
KEY POINTS
 Specific probiotics, prebiotics, or their combination
significantly influence host immunological networks.
 The immune responses to microbial components (e.g.
polysaccharides) and their metabolites (e.g. SCFA) are
being better characterized at a molecular level.
 The immune-modulatory effects of probiotics, prebiotics,
or synbiotics may be most potent when administered
early in life.
Nutrition
154 www.co-gastroenterology.com Volume 31  Number 2  March 2015
 Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
Histamine is another important mucosal meta-
bolite secreted by the gut microbes, and mucosal
histamine levels are increased in patients with
irritable bowel syndrome and inflammatory
bowel disease [18
&
]. Histamine is able to decrease
chemokine and proinflammatory cytokine secret-
ion induced by the Toll-like-receptor-stimulated
dendritic cells, while increasing IL-10 production
[19
&
]. Histamine exerted this effect by activating
the histamine 2 receptor (H2R) on dendritic cells
and the signaling mechanism required cyclic adeno-
sine monophosphate (cAMP) and exchange protein
directly activated by cAMP (EPAC). Administration
of a histamine-secreting Lactobacillus strain to mice
resulted in rapid weight loss and enhanced Peyer’s
patch cytokine secretion, which was exaggerated in
H2R-deficient animals [20
&&
].
Epithelial cells
Epithelial cells play an essential role in nutrient
absorption. Pathogen-induced reductions in epi-
thelial cell digestive enzyme activity can be blocked
by Bifidobacterium infantis 35624, possibly via modu-
lation of mucosal inflammatory responses [21,22
&
].
In addition to their absorptive function, epithelial
cells form a mucosal barrier that protects host tissue
from damaging agents such as luminal pathogens
and toxic products. One protective barrier mechan-
ism is the production and secretion of antimicrobial
peptides, such as defensins and cathelicidins. Pro-
biotic strains have been shown to differentially
regulate defensin expression and protein secretion,
which is influenced by local inflammatory
mediators [23]. Autophagy is an important adaptive
response to stress, which promotes cell survival and
is required for the maintenance of the epithelial
barrier. A number of Bifidobacteria have been
recently described that promote autophagy in an
intestinal cell line [24]. The mucus layer coating the
gastrointestinal tract is an important barrier com-
ponent and probiotics have been shown to promote
mucin production by goblet cells in the intestine.
Recently, p40 from Lactobacillus GG was demon-
strated to be sufficient for the stimulation of mucin
production through transactivation of the epider-
mal growth factor receptor [25
&
]. Excessive epithelial
cell responses to microbial ligands result in local
inflammatory responses, which disrupt the epi-
thelial barrier. A wide range of probiotic microbes
have been demonstrated to suppress epithelial cell
proinflammatory chemokine responses [26
&
,27,28].
However, not all chemokine responses are impacted
to the same extent by every probiotic strain and a
single probiotic strain may reduce the expression of
certain chemokines, while increasing the expression
of others. For example, Bifidobacterium bifidum
PRL2010 suppresses CCL22 expression but enhances
CCL19 expression, suggesting that strain-specific
and chemokine-specific responses are induced by
probiotics [29
&
]. In addition, prebiotics themselves,
or SCFAs, can also modulate epithelial barrier func-
tion, production of antimicrobial peptides, and
secretion of proinflammatory mediators [30,31].
ADAPTIVE IMMUNE SYSTEM
The adaptive immune system receives polarizing
signals from the innate cells to expand an appro-
priately controlled lymphocyte response to bacterial
and metabolic factors. Recent evidence has
suggested a role for probiotic and prebiotic effects
on TREG cells, effector T cells, natural killer T (NKT)
cells, and B cells.
T lymphocytes
The beneficial effect of prebiotics, probiotics, and
synbiotics against diseases such as allergy or colitis is
often associated with enhancement of TREG cells
[32
&
,33]. Specific probiotics, but not all, have been
shown to induce an increase in TREG cells. Notably,
consumption of B. infantis 35624 by healthy human
volunteers resulted in an increased proportion of
Foxp3þ lymphocytes in peripheral blood, whereas
administration of this probiotic to psoriasis patients,
chronic fatigue syndrome patients, or ulcerative
colitis patients consistently resulted in reduced
levels of serum proinflammatory biomarkers such
as C-reactive protein, possibly mediated by
increased numbers of TREG cells [7,34
&&
].
In addition to probiotics, effects on lympho-
cytes can also be mediated by SCFAs such as acetate,
propionate, butyrate, and n-butyrate. Oral admin-
istration of a mixture of 17 Clostridia strains to
mice attenuated the severity of colitis and allergic
diarrhea in a TREG–TGF-b-dependent mechanism.
This process is most likely because of SCFAs
produced by the Clostridia strains [35,36
&&
].
G-protein-coupled receptor (GPCR) 43 has been
described as receptor for SCFAs. GPR43 signaling
ameliorates diseases such as colitis, inflammatory
arthritis, and allergic airway diseases [35,37
&
]. In
addition to the expression on neutrophils and eosi-
nophils, GPCR43 is expressed on colonic inducible
TREG cells and promotes their expansion and
IL-10 secretion.
As already described above for dendritic cells,
SCFAs inhibit HDAC activity also in lymphocytes
enhancing histone H3 acetylation in the promoter
and conserved noncoding sequence regions of the
Foxp3 locus [35,38
&
].
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Probiotic and commensal bacteria have been
shown to suppress TH17 responses through both
direct and indirect mechanisms. TH17 cells secrete
IL-17 that induces tissue inflammation. Probiotic
strains inhibit TH17 and IL-17 activity by inducing
TREG and TH1 subsets, by induction of IL-27 pro-
duction, which suppress the generation of IL-17 and
induce IL-10 or by stimulation of TLR9 on TH17 cells
[39].
Natural killer T cells
NKT cells are central mediators of intestinal inflam-
mation and pathogenic NKT cell activation is medi-
ated by CD1dþ bone-marrow-derived cells, whereas
CD1dþ epithelial cells protect against intestinal
inflammation [40]. It has been shown that NKT cells
can be influenced by the gut microflora and certain
probiotic lipid antigens may directly activate NKT
cells [41,42]. Recently, a healthy human volunteer
study showed that the combination of xylo-oligo-
saccharide with Bifidobacterium animalis reduced
CD16/CD56 expression on NKT cells and reduced
IL-10 secretion from peripheral blood mononuclear
cells in response to lipopolysaccharide [43
&
]. The
functional consequences of altered NKT cell acti-
vation by the microbiome in humans remain to
be determined.
B cells
B lymphocytes have an essential role in humoral
immune responses via their secretion of antigen-
specific antibodies. In addition, B cells can limit
aggressive immune reactivity. B cells regulate
immune responses mainly via IL-10, which has been
shown in the experimental models of infection,
allergic inflammation, and tolerance [44].
B-cell-dependent modulation of the micro-
biome was shown in IgA-deficient mice. IgA-
deficient mice had persistent intestinal colonization
with g-Proteobacteria that cause sustained intestinal
inflammation and increased susceptibility to neo-
natal and adult models of intestinal injury. The
group also identified an IgA-dependent mechanism
responsible for the maturation of the intestinal
microbiota in mice [45]. Recently, another group
showed that the number of gut-homing IgGþ and
IgAþ B cells was significantly higher in infants com-
pared with adults. This suggests that activation of
naı¨ve B cells in the gut overlaps with the establish-
ment of the gut microbiota in humans [46]. Oral
administration of Lactobacillus gasseri SBT2055
(LG2055) induced IgA production and increased
the number of IgAþ cells in Peyer’s patches and in
the lamina propria. Combined stimulation of B cells
with B-cell activating factor and LG2055 enhanced
the induction of IgA production. IgA plays an
important role in host defense against mucosally
transmitted pathogens, prevents commensal bac-
teria from binding to epithelial cells, and neutralizes
their toxins to maintain homeostasis at the mucosal
surfaces [47].
It was recently shown that the gut microbiota
induces dendritic cells and macrophages to
produce IL-1b and IL-6, which both drive TH17
differentiation and arthritis. The same signals also
induced the differentiation of IL-10-producing B
regulatory cells. These data suggest that the
commensal microbiota is important for inducing
both proinflammatory and regulatory responses in
order to rapidly clear infections and minimize
the inflammation-associated tissue damage
[48
&&
]. Interestingly, supplementation with xylo-
oligosaccharide and B. animalis in a human
study led to reduced expression of CD19 on B cells
[43
&
].
AGE-DEPENDENT EFFECTS OF
PROBIOTICS, PREBIOTICS, AND
SYNBIOTICS
The timing of bacterial colonization early in life is
thought to be important for appropriate immune
education and the transmission from mother to the
fetus during pregnancy and birth is being better
described. Cultures of meconium have shown
diverse groups of Gram-positive and Gram-negative
bacteria, possibly not all derived after delivery. The
development of the gut microbiome is a dynamic
process and early colonization with Bacteroides and
Bifidobacterium species might play a crucial role in
the development of immune regulation [49
&
]. Fac-
tors that can influence early-life colonization
include antibiotic treatment, method of delivery,
maternal and infant diet, and biodiversity in the
home, surrounding environment and in family
members.
The immune system at birth is dominated by the
TH2 cells. However, the human fetus has a func-
tional immune system at a relative early status of
development comprising not only CD4þ and CD8þ
T cells, but also FOXP3þ TREG cells. One concept
gaining support is that the developing fetus may
become educated by whole bacteria or their genetic
material that is provided via maternal serum. DNA
from Bifidobacteria and Lactobacilli, two genera
typically used as probiotics, are found in human
placenta. In contrast, in-utero exposure to poten-
tially pathogenic bacteria such asUreaplasma species
leads to immune dysregulation, commonly ending
in fatal complications [50]. Maternal consumption
Nutrition
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of probiotic-containing food components may
reduce the risk for childhood allergic diseases, and
mouse models demonstrate a reduced risk of inflam-
matory bowel diseases [50]. Epigenetic mechanisms
may be critical as application of Acinetobacter lwoffii
to pregnant mice reduced the airway hypersensitiv-
ity response of the offspring. The promoter region of
IFN-g in CD4þ T cells of the offspring had high levels
of histone-4 acetylation, associated with enhanced
transcription, whereas the IL-4 promoter region had
lower levels of histone-4 acetylation. Moreover,
exposure of pregnant mothers to the farm environ-
ment, which has high levels of A. lwoffii, was associ-
ated with DNA demethylation of the Foxp3 locus
and methylation of the TH2-associated genes RAD50
and IL-13 [50].
As the gut microbiota composition during the
first months of life seems to be important for the
development of appropriate immune regulatory
networks and thereby influences later life disease
risk, intervention with probiotics, prebiotics, or syn-
biotics might be most effective at this age or even
during pregnancy.
CONCLUSION
Appropriately selected probiotics, prebiotics, or
their combination exert potent effects on the
immune system. Of particular interest are the
recent findings on the molecular mechanisms
underpinning the effects of SCFAs on immune cells.
However, it is highly likely that SCFAs are only one
example of the many bacterial metabolites which
influence immune cells. A better description of the
bacterial strains and metabolites which influence
immune function will allow for improved design
of future probiotic and prebiotic cocktails for the
prevention and treatment of immunological
disorders.
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